Rating Overview and Context
On 14 August 2025, MarketsMOJO revised the rating for Integrated Proteins Ltd from 'Sell' to 'Strong Sell', reflecting a significant deterioration in the company’s overall investment appeal. The Mojo Score, a composite measure of quality, valuation, financial trend, and technical factors, dropped sharply by 15 points from 31 to 16. This rating signals a cautious stance for investors, suggesting that the stock currently carries considerable risks and may underperform relative to the broader market.
Here’s How the Stock Looks Today
As of 10 February 2026, Integrated Proteins Ltd remains a microcap player in the edible oil sector, with financial and market indicators that continue to raise concerns. The company’s stock price has experienced notable volatility, with a one-day gain of 5.00% but a one-year return of -55.13%, significantly underperforming the BSE500 index, which has delivered a positive 10.60% return over the same period.
Quality Assessment
The company’s quality grade is rated below average, reflecting weak long-term fundamental strength. Integrated Proteins Ltd has an average Return on Equity (ROE) of just 1.51%, indicating limited profitability relative to shareholder equity. Operating profit growth has been modest, with an annualised increase of 7.86% over the past five years, which is insufficient to drive robust shareholder value. Furthermore, the company’s ability to service its debt is poor, as evidenced by an average EBIT to interest ratio of -0.05, signalling potential financial stress and limited operational efficiency.
Valuation Considerations
Valuation metrics paint a challenging picture for investors. The stock is considered very expensive, trading at a Price to Book Value ratio of 2.6, which is a premium compared to its peers’ historical averages. This elevated valuation is difficult to justify given the company’s weak profitability and flat financial trends. Despite the stock’s significant price decline over the past year, the company’s profits have actually risen by 26%, suggesting a disconnect between market pricing and underlying earnings performance. This disparity may reflect investor scepticism about the sustainability of profit growth or concerns about other risk factors.
Financial Trend Analysis
The financial grade for Integrated Proteins Ltd is flat, indicating stagnation rather than growth or decline. The company reported flat results in the September 2025 quarter, which aligns with the broader trend of limited improvement in key financial metrics. This lack of momentum in earnings and cash flow generation contributes to the cautious rating, as investors typically seek companies demonstrating clear upward financial trajectories.
Technical Outlook
From a technical perspective, the stock is rated bearish. Recent price movements show a downward trend over the medium term, with three-month and six-month returns of -22.54% and -35.66% respectively. The stock’s inability to sustain gains and its underperformance relative to market benchmarks suggest weak investor sentiment and potential further downside risk. The one-month return of -8.94% and year-to-date decline of -13.87% reinforce this negative technical outlook.
Implications for Investors
The Strong Sell rating from MarketsMOJO indicates that investors should exercise caution with Integrated Proteins Ltd. The combination of below-average quality, expensive valuation, flat financial trends, and bearish technical signals suggests that the stock may continue to face headwinds. For risk-averse investors, this rating serves as a warning to avoid initiating new positions or to consider reducing exposure if already invested. Conversely, more speculative investors might view the current valuation and profit growth as potential opportunities, but these come with heightened risk.
Our latest monthly pick, this Small Cap from Oil Exploration/Refineries, is showing strong performance since announcement! See why our Investment Committee chose it after screening 50+ candidates.
- - Investment Committee approved
- - 50+ candidates screened
- - Strong post-announcement performance
Stock Performance in Context
Integrated Proteins Ltd’s stock performance has been disappointing relative to the broader market and its sector peers. While the edible oil sector has faced its own challenges, the company’s returns have lagged significantly. The stock’s 55.13% decline over the past year contrasts sharply with the 10.60% gain in the BSE500 index, highlighting its underperformance. This divergence underscores the importance of considering both company-specific fundamentals and broader market conditions when evaluating investment opportunities.
Financial Metrics Summary
As of 10 February 2026, key financial metrics for Integrated Proteins Ltd include:
- Return on Equity (ROE): 1.6%
- Operating Profit Growth (5-year CAGR): 7.86%
- EBIT to Interest Coverage Ratio: -0.05 (negative)
- Price to Book Value: 2.6
- Profit Growth (past year): +26%
These figures illustrate a company with limited profitability and financial strain, yet trading at a valuation premium that may not be justified by its fundamentals.
Conclusion
Integrated Proteins Ltd’s current Strong Sell rating by MarketsMOJO reflects a comprehensive assessment of its quality, valuation, financial trends, and technical outlook. Investors should be aware that despite some profit growth, the company’s weak fundamentals and bearish market signals present significant risks. The rating serves as a guide to approach the stock with caution, prioritising risk management and thorough analysis before considering any investment.
Unlock special upgrade rates for a limited period. Start Saving Now →
